Clinical Trial Update: Abciximab, Clopidogrel and Percutaneous Coronary Intervention in Acute Coronary Syndrome (ISAR-REACT-2) [Phase 4]

View source ↗

Summary

Phase 4 ISAR-REACT-2 trial evaluating Abciximab and Clopidogrel with percutaneous coronary intervention in acute coronary syndrome; the trial status is COMPLETE…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Syndrome
• Unstable Angina

Drugs mentioned

• Abciximab (abciximab)
• CLOPIDOGREL (CLOPIDOGREL)

Snippet

Sponsor: Deutsches Herzzentrum Muenchen | Conditions: Coronary Disease, Angina, Unstable | Phase 4 | Status: COMPLETED